FDA Brief: Week of Mar 21, 2016

 

FDA Voice

 

Addressing Issues Relating to Combination Products: Human Factors (HF)

By:

Jill Hartzler Warner, J.D., Associate Commissioner for Special Medical Programs

Thinh Nguyen, Director, Office of Combination Products

  • Combination products combine a drug, device, and/or biological product

May be physically or chemically combined; co-packaged; or separately distributed with specific labeling for combined use

  • If medical device constituent – HF engineering important for safe and effective use

Study how people interact with technology, how design of user interfaces affects  quality, experience, and outcomes of interaction

  • Feb 2016, draft guidance on HF studies (posted in BLOG )
    • timing and sequencing
    • new studies to qualify product changes
    • simulated vs actual use
    • FDA requirements
  • FDA seeking comments on draft

 

 

READ


 

 

 

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s